uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Clinical and prognostic implications of circulating pentraxin 3 levels in non ST-elevation acute coronary syndrome
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences, Cardiology.
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences, Cardiology.
Show others and affiliations
2013 (English)In: Clinical Biochemistry, ISSN 0009-9120, E-ISSN 1873-2933, Vol. 46, no 16-17, 1655-1659 p.Article in journal (Refereed) Published
Abstract [en]

Objectives: Pentraxin 3 (PTX3) is the prototype of the long pentraxin family. PTX3 is involved in inflammatory processes affecting the cardiovascular system, and PTX3 levels have been shown to be elevated and independently prognostic in ST-elevation myocardial infarction. Data on PTX3 levels in non-ST-elevation acute coronary syndrome (NSTE-ACS), in contrast, are limited. The aim of the present analysis was to investigate the implications of PTX3 levels in a fairly large sample of NSTE-ACS patients and in comparison to levels of C-reactive protein (CRP). Design and methods: We measured levels of PTX3 and CRP in both 82 healthy controls and 401 NSTE-ACS patients from the GUSTO IV study, and studied the associations of these biomarkers to clinical data and 1-year mortality. Results: NSTE-ACS patients had significantly higher median PTX3 levels compared to healthy controls (3.8 vs. 1.9 mu g/L; p < 0.001). PTX3 levels in patients with NSTE-ACS were independently related to female sex and cardiac troponin T levels, but not to age or cardiovascular risk factors. PTX3 levels were higher in patients who died within 1 year but did not emerge as an independent predictor of 1-year mortality (adjusted OR 1,2 [95% Cl 0.6-2.31). This was in contrast to CRP (adjusted OR 1.5 [95% Cl 1.1-2.3]). Neither PTX3 nor CRP yielded significant discriminative value regarding mortality prediction. Conclusions: PTX3 levels are elevated in NSTE-ACS. However, the prognostic information provided by PTX3 levels is limited and inferior compared to CRP. Our data, thus, do not support the measurement of PTX3 in patients with NSTE-ACS.

Place, publisher, year, edition, pages
2013. Vol. 46, no 16-17, 1655-1659 p.
Keyword [en]
Pentraxin 3, Inflammatory biomarkers, Acute coronary syndrome, Mortality, Outcome prediction
National Category
Medical and Health Sciences
URN: urn:nbn:se:uu:diva-211767DOI: 10.1016/j.clinbiochem.2013.08.014ISI: 000326362100007OAI: oai:DiVA.org:uu-211767DiVA: diva2:669116
Available from: 2013-12-03 Created: 2013-12-02 Last updated: 2013-12-03Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full text

Search in DiVA

By author/editor
Eggers, Kai M.Johnston, NinaVenge, PerJames, Stefan K.
By organisation
CardiologyBiochemial structure and functionUCR-Uppsala Clinical Research Center
In the same journal
Clinical Biochemistry
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar

Altmetric score

Total: 133 hits
ReferencesLink to record
Permanent link

Direct link